Literature DB >> 29330269

Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation.

Karolina Polchlopek Blasiak1, Federico Simonetta1, Maria-Isabel Vargas2, Yves Chalandon1.   

Abstract

A 60-year-old man presented with impaired consciousness and psychomotor agitation after a second allogeneic haematopoietic stem cell transplantation (HSCT) from a matched unrelated donor for acute myeloid leukaemia. Clinical, biological and radiological evidence suggested a diagnosis of central nervous system graft-versus-host disease (CNS-GvHD). After intrathecal infusion of methylprednisolone, the clinical symptoms as well as the radiological abnormalities disappeared. The present report illustrates the difficulties in the diagnosis and the management of CNS-GvHD, a very rare and still challenging neurological complication that can occur after allogeneic HSCT. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (incl blood transfusion); neuroimaging; neurology

Mesh:

Substances:

Year:  2018        PMID: 29330269     DOI: 10.1136/bcr-2017-221840

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Central nervous system graft-versus-host disease in a 68-year-old man presenting with myoclonus.

Authors:  Xin Wang; Maxime Billick; Danny Monsour; Jessica Liu
Journal:  CMAJ       Date:  2019-09-30       Impact factor: 8.262

2.  Neurologic complications after allogeneic transplantation: a meta-analysis.

Authors:  Maria Gavriilaki; Maria Mainou; Eleni Gavriilaki; Anna-Bettina Haidich; Sotirios Papagiannopoulos; Ioanna Sakellari; Achilles Anagnostopoulos; Vasilis Kimiskidis
Journal:  Ann Clin Transl Neurol       Date:  2019-09-27       Impact factor: 4.511

3.  Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia.

Authors:  Yanni Sun; Jia Wan; Qiuyue Song; Chengxin Luo; Xi Li; Yanrong Luo; Xiangtao Huang; Ruiheng Ding; Hui Li; Yu Hou; Yongxiu Huang; Mingling Xie; Zhen Huang; Yali Zhang; Yanni Ma; Guixian Wu; Shuangnian Xu; Jieping Chen
Journal:  Biomed Res Int       Date:  2021-04-08       Impact factor: 3.411

Review 4.  Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yuta Kaito; Shunsuke Yui; Kazuki Inai; Daishi Onai; Ryosuke Kinoshita; Satoshi Yamanaka; Muneo Okamoto; Ryuichi Wada; Ryuji Ohashi; Koiti Inokuchi; Hiroki Yamaguchi
Journal:  Intern Med       Date:  2021-10-15       Impact factor: 1.271

Review 5.  Acute Graft-Versus-Host Disease, Infections, Vascular Events and Drug Toxicities Affecting the Central Nervous System.

Authors:  Janaki Manoja Vinnakota; Robert Zeiser
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.